Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Danaher
(NYSE:DHR)
Intraday
$245.80
0
[0.00%]
After-Hours
$245.80
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$245.80
0
[0.00%]
At close: Apr 25
$245.80
0
[0.00%]
PreMarket: 4:00PM EDT
Get Report
Watch
Q1 2024 Earnings were released on Tue Apr 23rd, before the market open
The most recent conference call was at 8:00 AM, 3 days ago
Click to view past webcast
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Danaher Stock (NYSE:DHR)
Danaher Stock (NYSE: DHR)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, April 24, 2024
Citigroup Maintains Buy on Danaher, Raises Price Target to $290
Benzinga Newsdesk
-
1 day ago
TD Cowen Maintains Buy on Danaher, Raises Price Target to $290
Benzinga Newsdesk
-
1 day ago
B of A Securities Maintains Neutral on Danaher, Raises Price Target to $270
Benzinga Newsdesk
-
1 day ago
Barclays Maintains Equal-Weight on Danaher, Raises Price Target to $270
Benzinga Newsdesk
-
1 day ago
Tesla To $180? Here Are 10 Top Analyst Forecasts For Wednesday
Avi Kapoor
-
1 day ago
Baird Maintains Outperform on Danaher, Raises Price Target to $271
Benzinga Newsdesk
-
1 day ago
Tuesday, April 23, 2024
Stocks Rally On Weaker PMI Data, Tech Earnings Optimism, Dollar Falls: What's Driving Markets Tuesday?
Piero Cingari
-
2 days ago
HealthStream Reports Upbeat Results, Joins Spotify, Ryder System And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
-
2 days ago
Why Is Life Science-Focused Danaher Trading Higher On Tuesday?
Vandana Singh
-
2 days ago
Earnings Scheduled For April 23, 2024
Benzinga Insights
-
2 days ago
Danaher shares are trading higher following better-than-expected Q1 financial results.
Benzinga Newsdesk
-
2 days ago
Danaher Continues To Expect Fy2024 Adjusted Core Revenue To Be Down Low-single Digits YoY
Benzinga Newsdesk
-
2 days ago
For Q2 2024, Danaher Anticipates That Adjusted Core Revenue Will Be Down Mid-single Digits YoY
Benzinga Newsdesk
-
2 days ago
Danaher Q1 2024 Adj EPS $1.92 Beats $1.71 Estimate, Sales $5.796B Beat $5.622B Estimate
Benzinga Newsdesk
-
3 days ago
Monday, April 22, 2024
Spotlight on Danaher: Analyzing the Surge in Options Activity
Benzinga Insights
-
3 days ago
Thursday, April 18, 2024
If You Invested $100 In This Stock 10 Years Ago, You Would Have $500 Today
Benzinga Insights
-
Apr 18, 2024, 12:00PM
Wednesday, April 17, 2024
Forecasting The Future: 7 Analyst Projections For Danaher
Benzinga Insights
-
Apr 17, 2024, 12:01PM
HSBC Upgrades Danaher to Buy, Raises Price Target to $280
Benzinga Newsdesk
-
Apr 17, 2024, 10:40AM
Friday, April 12, 2024
This Is What Whales Are Betting On Danaher
Benzinga Insights
-
Apr 12, 2024, 1:32PM
Wednesday, April 10, 2024
Barclays Maintains Equal-Weight on Danaher, Raises Price Target to $260
Benzinga Newsdesk
-
Apr 10, 2024, 3:33PM
Monday, April 08, 2024
Jim Cramer Isn't Going With This Tech Company: 'It's Complicated. I'm A Nvidia Guy'
Avi Kapoor
-
Apr 8, 2024, 8:26AM
Thursday, April 04, 2024
Unpacking the Latest Options Trading Trends in Danaher
Benzinga Insights
-
Apr 4, 2024, 4:16PM
Monday, April 01, 2024
Danaher Corp Files For Mixed Shelf; Size Not Disclosed
Benzinga Newsdesk
-
Apr 1, 2024, 4:26PM
Thursday, March 28, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
-
Mar 28, 2024, 1:35PM
Wednesday, March 27, 2024
Danaher Options Trading: A Deep Dive into Market Sentiment
Benzinga Insights
-
Mar 27, 2024, 12:01PM
Tuesday, March 26, 2024
Looking Into Danaher's Recent Short Interest
Benzinga Insights
-
Mar 26, 2024, 3:15PM
Monday, March 25, 2024
If You Invested $100 In This Stock 10 Years Ago, You Would Have $500 Today
Benzinga Insights
-
Mar 25, 2024, 10:00AM
Wednesday, March 20, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
-
Mar 20, 2024, 1:35PM
Friday, March 15, 2024
Danaher's Options Frenzy: What You Need to Know
Benzinga Insights
-
Mar 15, 2024, 3:31PM
Here's How Much $1000 Invested In Danaher 5 Years Ago Would Be Worth Today
Benzinga Insights
-
Mar 15, 2024, 10:00AM
Wednesday, March 13, 2024
Top 7 Biotech Stock Winners As Weight Loss Drug Battle Escalates: Goldman Sachs Names Best Picks
Piero Cingari
-
Mar 13, 2024, 12:35PM
Wednesday, February 28, 2024
$1000 Invested In Danaher 10 Years Ago Would Be Worth This Much Today
Benzinga Insights
-
Feb 28, 2024, 9:00AM
Tuesday, February 27, 2024
Danaher's Spun-Off Company Veralto Is "Next High-Quality Serial Compounder" - Analyst
Lekha Gupta
-
Feb 27, 2024, 2:15PM
Beyond Tech And AI: Why The Sector Hedge Funds Prefer Is Not The One You'd Expect
Piero Cingari
-
Feb 27, 2024, 12:34PM
Thursday, February 22, 2024
Unpacking the Latest Options Trading Trends in Danaher
Benzinga Insights
-
Feb 22, 2024, 1:45PM
Thursday, February 15, 2024
Engaging In Options Activity, Georgeann Couchara Exercises Options Valued At $465K In Danaher
Benzinga Insights
-
Feb 15, 2024, 10:01AM
Wednesday, February 14, 2024
Behind the Scenes of Danaher's Latest Options Trends
Benzinga Insights
-
Feb 14, 2024, 3:01PM
Tuesday, February 06, 2024
Here's How Much You Would Have Made Owning Danaher Stock In The Last 10 Years
Benzinga Insights
-
Feb 6, 2024, 11:30AM
Thursday, February 01, 2024
AT&T To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday
Avi Kapoor
-
Feb 1, 2024, 7:48AM
Keybanc Maintains Overweight on Danaher, Raises Price Target to $290
Benzinga Newsdesk
-
Feb 1, 2024, 5:03AM
Wednesday, January 31, 2024
Citigroup Maintains Buy on Danaher, Raises Price Target to $280
Benzinga Newsdesk
-
Jan 31, 2024, 3:37PM
Danaher Analysts Increase Their Forecasts After Upbeat Earnings
Avi Kapoor
-
Jan 31, 2024, 11:39AM
RBC Capital Maintains Outperform on Danaher, Raises Price Target to $282
Benzinga Newsdesk
-
Jan 31, 2024, 11:33AM
Raymond James Maintains Outperform on Danaher, Raises Price Target to $270
Benzinga Newsdesk
-
Jan 31, 2024, 8:10AM
Tuesday, January 30, 2024
US Stocks Ease Ahead Of Key Tech Earnings, UPS Sinks, General Motors Rallies: What's Driving Markets Tuesday?
Piero Cingari
-
Jan 30, 2024, 1:31PM
Life Science Giant Danaher Warns Of Sales Decline In 2024; Says 'Pandemic Has Transitioned To An Endemic State'
Vandana Singh
-
Jan 30, 2024, 11:26AM
Danaher shares are trading higher following better-than-expected Q4 financial results.
Benzinga Newsdesk
-
Jan 30, 2024, 10:15AM
For Q1 2024, Danaher Anticipates That Non-GAAP Core Revenue Will Be Down High-single Digits Y/Y. For FY2024, The Company Anticipates That Non-GAAP Core Revenue Will Be Down Low-single Digits Y/Y
Benzinga Newsdesk
-
Jan 30, 2024, 6:05AM
Danaher Q4 Adjusted EPS $2.09 Beats $1.89 Estimate, Sales $6.41B Beat $6.09B Estimate
Benzinga Newsdesk
-
Jan 30, 2024, 6:02AM
Earnings Scheduled For January 30, 2024
Benzinga Insights
-
Jan 30, 2024, 5:08AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch